Home | Welcome to Contract Pharma   
Last Updated Tuesday, May 5 2015

Print

Topics - Drug Development


Refine by Date:
From: To:
Published May 1, 2015
Validates undisclosed target to treat a neurological disorder Read More »
Published April 28, 2015
Specialty Injectable Pharmaceuticals up 13% Read More »
Published April 23, 2015
Will initiate a GLP toxicity study Read More »
Published April 23, 2015
Initiates Phase III Trial Read More »
Published April 20, 2015
Will evaluate birinapant in combination with KEYTRUDA in solid tumors Read More »
Published April 17, 2015
Samcyprone used for the treatment of malignant melanoma stage IIb to IV Read More »
Published April 16, 2015
Reicin brings extensive research and leadership experience Read More »
Published April 16, 2015
Aims to accelerate clinical trial processes Read More »
Published April 16, 2015
Will conduct combination trails in melanoma Read More »
Published April 15, 2015
Will provide discovery and development services from gene to candidates and beyond Read More »
Published April 15, 2015
Alliance expanded to include select pre-commercialization activities Read More »
Published April 15, 2015
Plans to progress development candidate through IND-enabling studies Read More »
Published April 14, 2015
Batra to lead the combined life science business Read More »
Published April 14, 2015
Will partner to develop new compounds Read More »
Published April 14, 2015
Clinical ops to occupy 9,000 sq. ft. facility by mid-2015 Read More »


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On